US Cancer Induced Bone Disease Therapeutics Market valued at $546 Mn in 2022, projected to reach $736 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include an upward trend in the incidence of cancer, an expanding therapeutic landscape, treatment advancements, and others. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Medtronic, Novartis, Fresenius, and Johnson & Johnson, among others.
The Japan Clinical Nutrition Market was valued at $1906.4 Mn in 2023 and is projected to grow at a CAGR of 5.84% from 2023 to 2023, to $2836.4 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto, Abbott Nutrition, Nestle, Mead Johnson & Company, LLC among others.
South Africa Dental Endodontics Market was valued at $11.40 Mn in 2023 and is predicted to grow at a CAGR of 5.53% from 2023 to 2030, to $16.60 Mn by 2030. The key drivers of this industry include rising awareness of oral health, a growing geriatric population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The Japan Breast Pump Market was valued at $182.8 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $336.2 Mn by 2030. The key drivers of the market include increasing female workforce participation, government support, and technological advancements. The prominent players in the Japan Breast Pump Market are Horigen, Pigeon, Asia Connection, Philips Avent, Ardo Medical AG, Youha, and Magneto, among others.
Singapore Cancer Induced Bone Disease Therapeutics Market valued at $2 Mn in 2022, projected to reach $3 Mn by 2030 with a 6.4% CAGR. The key drivers of this industry include the rising incidence of cancer, technological advancements, and increased government funding. The industry is primarily dominated by players such as Radius Health, Bayer, Merck, Eli Lilly, Teva, Johnson & Johnson, Amgen, and Novartis among others.
The Malaysia Clinical Nutrition Market was valued at $49.3 Mn in 2023 and is projected to grow at a CAGR of 5.54% from 2023 to 2023, to $71.9 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Bioalpha, Yakult, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd, Mead Johnson & Company, LLC among others.
India Dental Endodontics Market was valued at $31.80 Mn in 2023 and is predicted to grow at a CAGR of 7.3% from 2023 to 2030, to $52.10 Mn by 2030. The key drivers of this industry include rising awareness of oral health, rising prevalence of dental problems, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The Malaysia Breast Pump Market was valued at $4.7 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $8.5 Mn by 2030. The key drivers of the market include changing consumer preferences, increasing presence of females in the workforce, and growing consumer awareness. The prominent players of the Malaysia Breast Pump Market are Ameda, Pigeon, Horigen, Philips Avent, and Ardo Medical AG, among others.
Spain Cancer Induced Bone Disease Therapeutics Market valued at $25 Mn in 2022, projected to reach $37 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include the increase in the incidence of cancers, unmet medical needs, and technological advancements. The industry is primarily dominated by players such as Advaxis, Takeda, Gradalis, Roche, Eli Lilly, Hikma, Bayer, and Amgen among others.
The Philippines Clinical Nutrition Market was valued at $67.5 Mn in 2023 and is projected to grow at a CAGR of 5.84% from 2023 to 2023, to $100.4 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Vitacare, BioEssence, United Laboratories, USANA Health Sciences, Mead Johnson & Company, LLC among others.
Canada Digital Biomarkers Market was valued at $232 Mn in 2023 and is predicted to grow at a CAGR of 22.3% from 2023 to 2030, to $949.45 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and increasing consumer health awareness. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
The Singapore Breast Pump Market was valued at $3.5 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $6.5 Mn by 2030. The key drivers of the market include the rising female workforce, enhanced features, and consumer awareness. The prominent players of the Singapore Breast Pump Market are Asia Connection, Pigeon, Playtex, Ameda, Avent, and Evenflo, among others.
Saudi Arabia Cancer Induced Bone Disease Therapeutics Market valued at $22 Mn in 2022, projected to reach $39 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the rising incidence of cancer, the expanding therapeutic landscape, supportive government initiatives, and others. The industry is primarily dominated by players such as Amgen, Julphar, Novartis, Janssen, Sanofi, Roche, and Celgene among others.
The Singapore Clinical Nutrition Market was valued at $36.8 Mn in 2023 and is projected to grow at a CAGR of 5.94% from 2023 to 2023, to $55.1 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as iX Biopharma, NTUC Health, Baxter, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc. among others.
US Digital Biomarkers Market was valued at $1,218 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $4,441.26 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and patient empowerment and engagement. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
The Philippines Breast Pump Market was valued at $6.5 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $11.9 Mn by 2030. The key drivers of the market include rising employment rate of women, increasing healthcare expenditure, and growing consumer awareness. The prominent players of the Philippines Breast Pump Market are Asia Connection, Philips Avent, Advin Healthcare, Ardo Medical AG, Tommee Tippe, and Spectra Baby, among others.
UK Cancer Induced Bone Disease Therapeutics Market valued at $34 Mn in 2022, projected to reach $46 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include the rising incidence of cancers, a favorable regulatory environment, and technological advancements. The industry is primarily dominated by players such as Advaxis, Takeda, Gradalis, Johnson & Johnson, Hikma, Cellectar, and Amgen among others.
The Vietnam Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 5.57% from 2023 to 2023, to $224.1 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Danone Nutrition, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc Ltd, Mead Johnson & Company, LLC among others.
Saudi Arabia Digital Biomarkers Market was valued at $49.30 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $219.73 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
The Vietnam Breast Pump Market was valued at $14.7 Mn in 2023 and is predicted to grow at a CAGR of 8.83% from 2023 to 2030, to $26.6 Mn by 2030. The key drivers of the market include the rising female workforce, enhanced features, and consumer awareness. The prominent players in the Vietnam Breast Pump Market are Asia Connection, Pigeon, Playtex, Ameda, Avent, and Evenflo, among others.
Philippines Cancer Induced Bone Disease Therapeutics Market valued at $3 Mn in 2022, projected to reach $5 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include increasing cancer incidence, expanding healthcare infrastructure, and government initiatives. The industry is primarily dominated by players such as Pharex Healthcare, Bayer, Merck, UniLab, TGP Group, Pascual Laboratories, Amgen, and Novartis among others.
The Egypt Clinical Nutrition Market was valued at $85.9 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $136.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Bio Pharma, Eva Pharma, Bio Pure, SEDICO, Abbott Nutrition, Mead Johnson & Company, LLC among others
UAE Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $62.82 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, government initiatives, increased tech adoption, and focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
The Egypt Breast Pump Market was valued at $8.2 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $16.1 Mn by 2030. The key drivers of the market include improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players in the Egypt Breast Pump Market are Bistos, Ameda, Avent, Evenflo, and Pigeon, among others.
Malaysia Cancer Induced Bone Disease Therapeutics Market valued at $2 Mn in 2022, projected to reach $3 Mn by 2030 with a 6% CAGR. The key drivers of this industry include the increasing cancer incidence, government initiatives, and improved healthcare infrastructure. The industry is primarily dominated by players such as IHH Healthcare, Bayer, Merck, Pharmaniaga, Duopharma, Maypharm, Amgen, and Novartis among others.